Literature DB >> 10969215

[Incidence of colorectal cancer in Bas-Rhin, trend and prediction in 2009].

D Eilstein1, G Hédelin, P Schaffer.   

Abstract

The colorectal cancer is one of the three most frequent cancers. It concerns more and more men and women and is a of heavy consequence for mortality and treatment. This study attempted to predict the incidence and the number of incident cases of colorectal cancer. The analysis is a Poisson regression based on an age-period-cohort model. The predicted value of the incidence of colon cancer, standardized on the world population (25-89 years old), is increasing with time: it is, in 2005-2009, 41.5 for 100,000 for the women and 104.9 for 100,000 for the men. For rectum cancer, the predicted value of incidence is, in 2005-2009, 22.9 for 100,000 for the women and 37.2 for 100, 000 for the men. During the period 2005-2009, the number of incident cases is, for colon, 1,195 women (the mean increase, every ten years, is 31%) and 2,254 men (the mean increase, every ten years, is 65%). During the same period, the number of incident cases is, for rectum, 640 women (the mean increase, every ten years, is 24%) and 807 men (the mean increase every ten years is 14%). These results are similar to those of other studies in Europe and in the World.

Entities:  

Mesh:

Year:  2000        PMID: 10969215

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  Remarkably reduced expression of FoxO3a in metaplastic colorectum, primary colorectal cancer and liver metastasis.

Authors:  Le-Ya He; Xin Wei; Lei Du; Lu Liu; Feng Xu; Jiang Min; Chuan Li; De-Ding Tao; Quan Chen; Jun-Bo Hu; Jian-Ping Gong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17

2.  Expression of HAX-1 in colorectal cancer and its role in cancer cell growth.

Authors:  Xiaolan Li; Jianwu Jiang; Rui Yang; Xiangshang Xu; Fayong Hu; Anding Liu; Deding Tao; Yan Leng; Junbo Hu; Jianping Gong; Xuelai Luo
Journal:  Mol Med Rep       Date:  2015-06-11       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.